DOI: Published online: October 15, 2025 1 Diabetes Care Center, Jinnouchi Hospital, Kumamoto, Japan 2 Division of Endocrinology and Metabolism, Department of Internal Medicine, Kurume University School of Medicine, Kurume, Japan 3 Kurinami Clinic, Kanzaki, Kumamoto, Japan 4 Division of Cardiovascular Medicine, Diabetes Care Center, Jinnouchi Hospital, Kumamoto, Japan 5 Division of Preventive Cardiology, Department of Cardiovascular Medicine, Kumamoto University Hospital, Kumamoto, Japan Corresponding author: Hideaki Jinnouchi
In contrast, incretin-based therapies, including GLP-1 receptor agonists (like semaglutide and dulaglutide) and the dual GIP/GLP-1 receptor agonist tirzepatide, do not cause glucosuria and therefore lack this specific mechanism for promoting fungal infections
By identifying how and why these toxins have built up, we create customized, effective detoxification strategies in Madison WI and Middleton WI that support the bodys natural ability to heal
DrWS: All the literature and information that started on peptides really began with insulin
